The Directory of Pharma Companies and News


Pharmaleads logo
Pharmaleads is an emerging pharmaceutical company developing innovative products for the management of acute and chronic severe pain, a growing market with significant unmet medical need. Pharmaleads’ drugs are based on its deep knowledge and understanding of enkephalins, a key element of the body’s natural pain management system. Pharmaleads’ products, (Dual ENKephalinase inhibitors) DENKIs, aim to protect enkephalins, hence increasing their local concentrations and thereby inducing a physiological analgesia which improves pain management.

Pharmaleads has two products in clinical development which are targeting four multi-billion markets:

PL265 is being developed for the treatment of neuropathic pain (oral) and ocular pain/dry eye syndrome (eye drops). PL37 is being developed for the treatment of post-surgical /breakthrough cancer pain as a substitute of injectable opiates (IV) and acute migraine pain (oral route) Pharmaleads was founded in 2000. It is headquartered in Paris, France, and is funded by Private investors.

Category: Pharmaco
Category: Pharmaco

0 results
Brought to you by - Latest Jobs in Pharma
Brought to you by - Latest Jobs in Pharma.